The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Allergan plc

NYSE: AGN
Last

(U.S.) $237.33

Today's change+2.04 +0.87%
Updated March 24 4:00 PM EDT. Delayed by at least 15 minutes.
 

Allergan plc

NYSE: AGN
Last

(U.S.) $237.33

Today's change+2.04 +0.87%
Updated March 24 4:00 PM EDT. Delayed by at least 15 minutes.

Allergan plc up (U.S.)$2.04

Allergan plc closed up Friday by (U.S.)$2.04 or 0.87% to (U.S.)$237.33. Over the last five days, shares are unchanged, but have gained 13.01% over the last year to date. This security has underperformed the S&P 500 by 30.16% during the last year.

Key company metrics

  • Open(U.S.) $235.35
  • Previous close(U.S.) $235.29
  • High(U.S.) $238.35
  • Low(U.S.) $234.86
  • Bid / Ask-- / --
  • YTD % change+13.01%
  • Volume2,688,552
  • Average volume (10-day)3,574,041
  • Average volume (1-month)3,262,041
  • Average volume (3-month)4,195,071
  • 52-week range(U.S.) $184.50 to (U.S.) $281.28
  • Beta1.12
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward14.80×
  • Forward PEG1.07×
  • Indicated annual dividend(U.S.) $2.80
  • Dividend yield1.18%
  • Trailing EPS(U.S.) -$3.12
Updated March 24 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.06%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue3,8643,6223,6853,399
Total other revenue--------
Total revenue3,8643,6223,6853,399
Gross profit3,3853,1603,2432,922
Total cost of revenue480462442477
Total operating expense4,7643,8894,1723,571
Selling / general / administrative1,2771,1571,2101,096
Research & development1,340665905409
Depreciation / amortization1,6391,6091,6331,590
Interest expense (income), net operating--------
Unusual expense (income)29-5-18-2
Other operating expenses, total--------
Operating income-900-266-488-172
Interest income (expense), net non-operating-293-324-346-333
Gain (loss) on sale of assets--------
Other--------
Income before tax-1,111-539-681-501
Income after tax-40-380-423-92
Income tax, total-1,071-159-258-409
Net income-115,220-502256
Total adjustments to net income-70-70-70-70
Net income before extra. items-42-382-424-93
Minority interest-2-2-2-1
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-112-452-494-163
Inc. avail. to common incl. extra. items-7015,150-571186
Diluted net income-7015,150-571186
Dilution adjustment--------
Diluted weighted average shares356393396395
Diluted EPS excluding extraordinary itemsvalue per share-0.31-1.15-1.25-0.41
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share-0.26-1.16-1.28-0.41